all report title image

PROTEIN ASSAYS MARKET ANALYSIS

Protein Assays Market, By Product Type (Reagents and Kits and Accessories), By Technology Type (Absorbance based Protein Assays, Colorimetric Protein Assays, and Fluorescence based Protein Assays), By End User (Pharmaceutical and Biotechnology Industry Clinical Laboratories, Hospitals, Academic Research Institutes, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

  • Published In : Aug 2024
  • Code : CMI1087
  • Pages :165
  • Formats :
      Excel and PDF
  • Industry : Medical Devices

Market Concentration and Competitive Landscape

Protein Assays Market Concentration By Players

Close-monitor your Competitor's Move, Request sample copy

Technological advancements in proteomics tools

Remarkable strides in systems biology approaches and omics technologies have transformed the field of proteomics in recent years. More powerful mass-spectrometers, microfluidics-based devices, high resolution microscopy tools and automated assay platforms have enhanced capabilities for comprehensive and in-depth protein analysis. Researchers can now analyze proteomes with greater accuracy, speed, resolution and throughput. Advancements such as single-cell proteomics, spatial proteomics, and quantitative standard-free proteomics are improving knowledge of molecular phenotypes. This widens scope and scale of proteomics studies. Growing sophistication of proteomics tools can offer new opportunities for development of synergistic multi-omics workflows. Integrating functional outputs of genomics and transcriptomics with insights from proteomics is key for building predictive models of cellular systems. Companies recognize the need for protein assays that can analyze thousands of samples not just from tissue lysates but other specimen types. Assays compatible with imaging mass-spectrometry are an example meeting this demand. Tools enabling characterization of protein isoforms and PTMswithin the same workflow boost statistical power of clinical studies. This transforms requirements for assays in terms of performance, scope and automation. Advancements like microfluidic chips, proximity extension assays and bead/array based assays improve precision, throughput and reduce sample volume needs. Newer assays require just picograms of protein for accurate quantification.

Key Players Insights
  • Thermo Fisher Scientific
  • Bio-Rad Laboratories
  • Merck KGaA
  • GE Healthcare
  • Hoffmann-La Roche
  • BD (Becton, Dickinson and Company)
  • Agilent Technologies
  • Promega Corporation
  • Abcamplc
  • PerkinElmer
  • Lonza
  • Bio-Techne
  • Cell Signaling Technology
  • Revvity
  • Zymo Research
  • Enzo Biochem
  • Takara Bio
  • Sigma-Aldrich (Merck Group)
  • Geno Technology
  • NanoString Technologies

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2025 Coherent Market Insights Pvt Ltd. All Rights Reserved.